U.S. Videos

Dan Sotiroff looks at performance and how it might have affected your portfolio.

Increased loan limits and special withdrawals are options for affected investors.

These funds are bloody, but unbowed.

Drug manufacturers are the most undervalued industry in the sector.

Tax and retirement planning expert Ed Slott says converting traditional IRA balances to Roth may cost you less in taxes now.

Alex Bryan discusses some ways to tackle risk in your current and future portfolio.

Christine Benz offers ideas for some investing habits we can put into place while cooped up at home that can pay dividends down the road.

Alex Bryan discusses areas that have performed worse than others during the recent market downturn.

Here are some of our favorite funds that invest in dividend growers.

Eric Jacobson explains why 2020 is indeed different.

How a short period of time plays a big role in returns.

Bookings Holdings, Expedia, and TripAdvisor face a competitive threat now that Google gets top billing on its own site.

Christine Benz explains why now isn't the time for grand gestures with your investments; instead, take a light touch to them.

Tax and retirement planning expert Ed Slott says investors should tread carefully among the potential provisions, from RMDs to hardship withdrawals and loans.

Eric Jacobson discusses bond fund performance.

The coronavirus fallout is hurting, but there should be a treatment by the year-end and the rebound will be strong, says Morningstar director of equities Johannes Faul.

Our research helps identify companies that might not be getting due credit for their economic moats.

The closure of the floor of the New York Stock Exchange will mostly mean business as usual -- with a few caveats.

This market hasn't been immune to trouble stemming from the coronavirus-related volatility.

Our thoughts for today, tomorrow, and the long term.

For near- and long-term goals and at any stage of life, Buckets help you keep your eyes on the prize.

We offer three picks in the most undervalued sector, energy.

Russ Kinnel shares which funds caught our eye because of a change in leadership.

Risks remain, but investors should consider the heavily discounted shares of this top healthcare pick.

Ben Johnson says that though they are growing in number and in assets, it's buyer beware on thematic funds.

Karen Andersen and Preston Caldwell give us their latest perspectives on healthcare and energy.

A hands-off policy for your portfolio amid market volatility is usually the best advice, but there are exceptions to that rule.

Don't flee the market in a panic, but rather embrace the turmoil as an investment opportunity--you'll be better off in the long run.

With COVID-19 comes an crucial need to ensure you're making the right moves.

Enterprise Products Partners reports another record-breaking quarter, with more good results ahead.

We discuss investor impact and taking a long view during the ongoing coronavirus outbreak.

Morningstar's director of ETF research in Asia talks about how investors are reacting in the ETF space.

Ben Johnson examines what type of ETF is best suited for this wrapper.

What we see as possibilities, whether the coronavirus leaves or lingers.

We offer three takeaways and advice on staying true to your goals.

Ben Johnson explains how ETFs might behave and affect the broader market in a serious market downdraft.

Our experts discuss the perks and perturbations of delaying your filing.

Morningstar recently cut the Analyst Ratings of these large funds.

With few competitors and a strong base, Workiva looks set to prosper.

Christine Benz offers some practical things that investors can do in this market uncertainty.

For core bond investors, these funds track the Bloomberg Barclays U.S. Aggregate Bond Index.

Lewis Kaufman, manager of Artisan Developing World, talks about his approach to emerging-markets investing.

Here's a look at Interpublic Group and Clorox, which were recently added to the Morningstar Dividend Yield Focus Index.

We expect modest auto market growth this year, with GM and Adient as standouts.

Alex Bryan discusses two picks for investors that should hold up over the long term.